Covaxin

Over 30% of Covaxin Recipients Experienced Health Issues After One Year

16 May 2024

A recent study conducted by researchers at BHU delved into the long-term effects of Bharat Biotech's Covaxin vaccine. The study, which spanned from January 2022 to August 2023, involved 926 participants who received the Covaxin vaccine. Among these participants, nearly one-third reported experiencing 'adverse events of special interest,' or AESI....

“Safety is primary focus for all our vaccines”: Covaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine

02 May 2024

Amidst concerns about potential rare side effects linked to the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, the creator of Covaxin, emphasized in a statement their unwavering dedication to prioritizing safety above all else in the development of their vaccine. They underscored that Covaxin was the exclusive COVID-19 vaccine in India's government...

Centre To Delhi High Court: Not Permissible To Take One Dose Of Covishield And Another Of Covaxin

27 Jan 2023

The Central Government in the case Madhur Mittal v. Union Of India observed and has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. The standing counsel appearing for Central Government’s Anurag Ahluwalia informed Justice...

DGCI Approves Covovax In Markets

17 Jan 2023

The Drugs Controller General of India (DCGI) has approved the official market business of Serum Institute of India's (SII) COVID-19 vaccine Covovax as a tertiary booster dose.This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin. Last December, the...

iNCOVACC nasal Covid vaccine will cost Rs 800 for private, Rs 325 for govt hospitals

27 Dec 2022

Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, has been approved by the center on Tuesday and at Rs 800 the vaccine will be available in private hospitals and government hospitals, it will be available for Rs 325. In the fourth week of January, the vaccine iNCOVACC will be rolled out. As...

AFTER PFIZER & SII, BHARAT BIOTECH SEEKS EMERGENCY USE NOD FOR COVID VACCINE

08 Dec 2020

New Delhi: Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine—Covaxin. The application was filed before the apex drug regulator on Monday evening, a company source told news agency IANS on the condition of anonymity....